Current innovations in mRNA vaccines for targeting multidrug-resistant ESKAPE pathogens

被引:1
作者
Imani, Saber [1 ]
Lv, Shuojie [1 ]
Qian, Hongbo [1 ]
Cui, Yulan [1 ]
Li, Xiaoyan [1 ]
Babaeizad, Ali [2 ]
Wang, Qingjing [1 ]
机构
[1] Zhejiang Shuren Univ, Shulan Int Med Coll, Key Lab Artificial Organs & Computat Med Zhejiang, Key Lab Pollut Exposure & Hlth Intervent Zhejiang, Hangzhou 310015, Zhejiang, Peoples R China
[2] Semnan Univ Med Sci, Fac Med, Semnan, Iran
关键词
mRNA vaccines; Multidrug-resistant; ESKAPE pathogens; Antigen selection; mRNA vaccine technology; CAPSULAR POLYSACCHARIDE VACCINE; ENTEROCOCCAL SURFACE PROTEIN; OUTER-MEMBRANE PROTEINS; III SECRETION SYSTEM; PSEUDOMONAS-AERUGINOSA; KLEBSIELLA-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; MOLECULAR-DETECTION; CANDIDATE VACCINE; VIRULENCE FACTORS;
D O I
10.1016/j.biotechadv.2024.108492
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The prevalence of multidrug-resistant (MDR) ESKAPE pathogens, including Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa, represents a critical global public health challenge. In response, mRNA vaccines offer an adaptable and scalable platform for immunotherapy against ESKAPE pathogens by encoding specific antigens that stimulate B-cell-driven antibody production and CD8+ T-cell-mediated cytotoxicity, effectively neutralizing these pathogens and combating resistance. This review examines recent advancements and ongoing challenges in the development of mRNA vaccines targeting MDR ESKAPE pathogens. We explore antigen selection, the nuances of mRNA vaccine technology, and the complex interactions between bacterial infections and antibiotic resistance. By assessing the potential efficacy of mRNA vaccines and addressing key barriers to their paraclinical implementation, this review highlights the promising function of mRNA-based immunization in combating MDR ESKAPE pathogens.
引用
收藏
页数:21
相关论文
共 261 条
[91]   Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors [J].
Jurado-Martin, Irene ;
Sainz-Mejias, Maite ;
McClean, Siobhan .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (06) :1-37
[92]  
Kareem Musafer H, 2022, Arch Razi Inst, V77, P1723, DOI [10.22092/ari.2022.358104.2153, 10.22092/ARI.2022.358104.2153]
[93]  
Kaufman O Ia, 1977, Biull Eksp Biol Med, V84, P112
[94]  
Khalaf E.A., 2018, Int. J. Green Pharm., V12, pS910
[95]   The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria [J].
Khalid, Kanwal ;
Poh, Chit Laa .
VACCINES, 2023, 11 (07)
[96]   Enterococcus faecium secreted antigen A generates muropeptides to enhance host immunity and limit bacterial pathogenesis [J].
Kim, Byungchul ;
Wang, Yen-Chih ;
Hespen, Charles W. ;
Espinosa, Juliel ;
Salje, Jeanne ;
Rangan, Kavita J. ;
Oren, Deena A. ;
Kang, Jin Young ;
Pedicord, Virginia A. ;
Hang, Howard C. .
ELIFE, 2019, 8
[97]   Iron Acquisition Systems of Gram-negative Bacterial Pathogens Define TonB-Dependent Pathways to Novel Antibiotics [J].
Klebba, Phillip E. ;
Newton, Salete M. C. ;
Six, David A. ;
Kumar, Ashish ;
Yang, Taihao ;
Nairn, Brittany L. ;
Munger, Colton ;
Chakravorty, Somnath .
CHEMICAL REVIEWS, 2021, 121 (09) :5193-5239
[98]   Photocaged 5′ cap analogues for optical control of mRNA translation in cells [J].
Kloecker, Nils ;
Weissenboeck, Florian P. ;
van Dulmen, Melissa ;
Spacek, Petr ;
Huewel, Sabine ;
Rentmeister, Andrea .
NATURE CHEMISTRY, 2022, 14 (08) :905-+
[99]   Plant lectin: A promising future anti-tumor drug [J].
Konozy, Emadeldin Hassan E. ;
Osman, Makarim El-fadil M. .
BIOCHIMIE, 2022, 202 :136-145
[100]   Current Perspectives and Future Prospects of mRNA Vaccines against Viral Diseases: A Brief Review [J].
Koppu, Vasavi ;
Poloju, Deepa ;
Puvvala, Bhavani ;
Madineni, Kavitha ;
Balaji, Shilpa ;
Sheela, Chandana Muraleedharan Pillai ;
Manchikanti, Sri Sai Charan ;
Moon, Satpathy Moon .
INTERNATIONAL JOURNAL OF MOLECULAR AND CELLULAR MEDICINE, 2023, 11 (03) :260-272